TY  - JOUR 
AU  - Akram, Javed
AU  - Saeed Khan, Khalid
PY  - 2020
UR  - http://hdl.handle.net/10481/66053
AB  - Objectives: To evaluate the effectiveness of Hydroxychloroquine Phosphate/Sulfate (200 mg orally 8 hourly thrice a
day for 5 days), versus oseltamivir (75 mg orally twice a day for 5 days), and versus Azithromycin (500 mg orally daily
on day 1,...
LA  - eng
PB  - BMC
KW  - COVID-19
KW  - Randomised controlled trial
KW  - Protocol
KW  - SARS-CoV-2
KW  - Hydroxychloroquine
KW  - Azithromycin
KW  - Oseltamivir
KW  - Multi-center
KW  - Adaptive
KW  - Randomization
TI  - Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
DO  - 10.1186/s13063-020-04616-4
ER  -